Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Milagros Fernández-Lucas"'
Autor:
Irene Martin Capon, Eduardo Gutierrez, Ana Huerta, Elizabeth Viera, Marta Alvarez Nadal, Milagros Fernández-Lucas, Javier Villacorta
Publikováno v:
Frontiers in Nephrology, Vol 4 (2024)
BackgroundThe treatment of minimal change disease (MCD) consists of a high dose of steroids for several months, implying significant drug toxicity. Nevertheless, relapses of steroid-sensitive MCD usually respond to lower doses of steroids.MethodsThe
Externí odkaz:
https://doaj.org/article/029bafcda0d74898b274f9855a27aa1d
Autor:
María de la Oliva Valentín, Domingo Hernández, Marta Crespo, Beatriz Mahillo, Isabel Beneyto, Itziar Martínez, Julia Kanter, Elena Calderari, Salvador Gil-Vernet, Sara Sánchez, Maria Luisa Agüera, Gabriel Bernal, Carlos de Santiago, Carmen Díaz-Corte, Cándido Díaz, Laura Espinosa, Carme Facundo, Milagros Fernández-Lucas, Tamara Ferreiro, Gorka García-Erauzkin, Teresa García-Alvarez, Pilar Fraile, Ana González-Rinne, María José González-Soriano, Esther González, Alex Gutiérrez-Dalmau, Carlos Jiménez, Ricardo Lauzurica, Inmaculada Lorenzo, Paloma L. Martín-Moreno, Francesc Moreso, María Carmen de Gracia, Isabel Pérez-Flores, Ana Ramos-Verde, Ignacio Revuelta, María Luisa Rodríguez-Ferrero, Juan Carlos Ruiz, Beatriz Sánchez-Sobrino, Beatriz Domínguez-Gil
Publikováno v:
Nefrología (English Edition), Vol 42, Iss 1, Pp 85-93 (2022)
Living donor kidney transplantation (LDKT) is the best treatment option for end stage renal disease in terms of both patient and graft survival. However, figures on LDKT in Spain that had been continuously growing from 2005 to 2014, have experienced
Externí odkaz:
https://doaj.org/article/87c6eeabe65d4936bdb8c6502306e926
Autor:
Emma Martínez-Alonso, Paula Alcázar, Emilio Camafeita, Milagros Fernández-Lucas, Gloria Ruíz-Roso, Alberto Alcázar
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract A large proportion of end-stage renal disease (ESRD) patients under long-term haemodialysis, have persistent anaemia and require high doses of recombinant human erythropoietin (rhEPO). However, the underlying mechanisms of renal anaemia have
Externí odkaz:
https://doaj.org/article/36861b2b137c43fa85bcd95055eda4ed
Autor:
José Ibeas, Ramon Roca-Tey, Joaquín Vallespín, Teresa Moreno, Guillermo Moñux, Anna Martí-Monrós, José Luis del Pozo, Enrique Gruss, Manel Ramírez de Arellano, Néstor Fontseré, María Dolores Arenas, José Luis Merino, José García-Revillo, Pilar Caro, Cristina López-Espada, Antonio Giménez-Gaibar, Milagros Fernández-Lucas, Pablo Valdés, Fidel Fernández-Quesada, Natalia de la Fuente, David Hernán, Patricia Arribas, María Dolores Sánchez de la Nieta, María Teresa Martínez, Ángel Barba
Publikováno v:
Nefrología (English Edition), Vol 37, Iss , Pp 1-191 (2017)
ABSTRACT: Vascular access for haemodialysis is key in renal patients both due to its associated morbidity and mortality and due to its impact on quality of life. The process, from the creation and maintenance of vascular access to the treatment of it
Externí odkaz:
https://doaj.org/article/84ba6fae8d1847e2a91ce2d506e8ad87
Autor:
José Luis Teruel, Víctor Burguera Vion, Antonio Gomis Couto, Maite Rivera Gorrín, Milagros Fernández-Lucas, Nuria Rodríguez Mendiola, Carlos Quereda
Publikováno v:
Nefrología (English Edition), Vol 35, Iss 3, Pp 273-279 (2015)
Introduction: Incidence of use for various renal replacement therapies is well known, but no data are available on the use of conservative treatment. Objective: To assess the proportion of patients with chronic kidney failure receiving conservative t
Externí odkaz:
https://doaj.org/article/7f9dde9193004a2c81bbcb16144d27a3
Autor:
José Luis Teruel, Víctor Burguera Vion, Antonio Gomis Couto, Maite Rivera Gorrín, Milagros Fernández-Lucas, Nuria Rodríguez Mendiola, Carlos Quereda
Publikováno v:
Nefrología, Vol 35, Iss 3, Pp 273-279 (2015)
Introducción: La incidencia de las diversas modalidades de tratamiento sustitutivo renal es conocida, pero no sucede así con la opción de tratamiento conservador. Objetivo: Conocer la proporción de pacientes con insuficiencia renal crónica somet
Externí odkaz:
https://doaj.org/article/1abd971d74554db993e87de99e6b68c1
Autor:
Fernando Caravaca, Victor Burguera, Milagros Fernández-Lucas, José Luis Teruel, Carlos Quereda
Publikováno v:
Case Reports in Nephrology, Vol 2014 (2014)
We describe an unusual case of subphrenic abscess complicating a central venous catheter infection caused by Pseudomonas aeruginosa in a 59-year-old woman undergoing hemodialysis. The diagnosis was made through computed tomography, and Pseudomonas ae
Externí odkaz:
https://doaj.org/article/805917aefffc4ceebcb2ca960c4fc5ec
Autor:
Marian Goicoechea, Vicente Álvarez, Alfonso Segarra, Manuel Polaina, Guillermo Martín-Reyes, Nicolás Roberto Robles, Verónica Escudero, Cristhian Orellana, Sergio Bea Granell, Joaquín de Juan-Ribera, Milagros Fernández Lucas, Jose Maria Graña, Javier Reque, Rosa Sánchez Hernández, Santiago Villamayor, Jose Luis Górriz
Publikováno v:
Nefrología, Vol 42, Iss 3, Pp 301-310 (2022)
Resumen: Antecedentes y objetivo: Describir las características clínicas de los pacientes tratados con evolocumab, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades
Externí odkaz:
https://doaj.org/article/5c5696b9aaff41f4be86267f461ae5f7
Autor:
Marta Álvarez Nadal, Nuria Rodríguez Mendiola, Martha Elizabeth Díaz Domínguez, Milagros Fernández Lucas
Publikováno v:
Hemodialysis International. 27:184-192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68db62555748b242fdbab6a642f08d7f
https://doi.org/10.1111/hdi.13074
https://doi.org/10.1111/hdi.13074
Autor:
R. Haridian Sosa Barrios, Víctor Burguera Vion, Milagros Fernández Lucas, Maite E. Rivera Gorrín
Publikováno v:
Journal of Nephrology. 35:2451-2457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::064130f1dde4b0da46ec6b281f2a96df
https://doi.org/10.1007/s40620-022-01420-y
https://doi.org/10.1007/s40620-022-01420-y